Apolipoprotein A-I Deficiency Results in Markedly Increased Atherosclerosis in Mice Lacking the LDL Receptor
- 1 October 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 23 (10) , 1914-1920
- https://doi.org/10.1161/01.atv.0000092328.66882.f5
Abstract
Objective— An inverse and independent association between plasma levels of apolipoprotein (apo) A-I and coronary heart disease in humans is well established. ApoA-I is the primary protein component of HDL and is thought to play an important role in mediating several of the atheroprotective effects of HDL. However, studies of the effects of apoA-I deficiency on the development of atherosclerosis in mice have not been definitive. We examined the effects of apoA-I deficiency on plasma lipids and atherosclerosis in LDL receptor-deficient mice fed a chow diet for up to 22 months. Methods and Results— Both apoA-I-deficient (apoA-I−/−)/LDL receptor-deficient (LDLR−/−) and LDLR−/− mice had a similar moderate elevation of non-HDL cholesterol (non-HDL-C). Unlike previous studies of apoA-I deficiency in which the HDL-C levels were extremely low, the apoA-I−/−/LDLR−/− mice in this study had substantial levels of HDL-C that were similar to wild-type mice. Despite similar levels of non-HDL-C and substantial levels of HDL-C, apoA-I−/−/LDLR−/− mice develop significantly more atherosclerosis (up to a 5-fold increase) and oxidant stress (39% increase) than LDLR−/− mice. Conclusions— These results demonstrate that despite normal levels of HDL-C, apoA-I deficiency is associated with a significant loss of protection from the formation of atherosclerosis in LDLR−/− mice fed a chow diet.Keywords
This publication has 31 references indexed in Scilit:
- Helical Apolipoproteins Stabilize ATP-binding Cassette Transporter A1 by Protecting It from Thiol Protease-mediated DegradationPublished by Elsevier ,2002
- Coronary artery disease in patients at low risk — apolipoprotein AI as an independent risk factorAtherosclerosis, 2001
- Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.Journal of Clinical Investigation, 1997
- Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.Journal of Clinical Investigation, 1994
- Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery diseaseThe American Journal of Cardiology, 1992
- Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities.Journal of Clinical Investigation, 1991
- Low serum apolipoprotein A-I in acute myocardial infarction survivors with normal HDL cholesterolAtherosclerosis, 1986
- Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery DiseaseNew England Journal of Medicine, 1983
- Familial Deficiency of Apolipoproteins A-I and C-III and Precocious Coronary-Artery DiseaseNew England Journal of Medicine, 1982